Sagehood (sagehood.ai) is the AI-powered investment research platform that placed #13 on Product Hunt's 2025 annual leaderboard with 643 upvotes in the Fintech and Investing categories. It deploys multiple specialised AI agents across US equity markets — each agent scanning a different data layer (earnings calls, SEC filings, analyst reports, insider trading activity, technical signals, news sentiment) — and synthesises findings into a unified 360° investment intelligence report for any US-listed stock. The intended outcome: research that previously took a professional analyst two to three hours to compile, delivered in minutes.
What Is Sagehood?
Sagehood's multi-agent architecture mirrors how an institutional research team is structured. Rather than one AI model attempting to cover all dimensions of stock analysis, Sagehood assigns distinct AI agents to specific data types — a fundamental analysis agent processes financial statements and earnings call transcripts, a sentiment agent monitors news and social signals, a technical analysis agent evaluates price action and momentum indicators, and a regulatory agent tracks insider transactions and SEC disclosure patterns. The synthesis layer combines these agent outputs into a coherent investment thesis with risk flags and supporting evidence.
The platform is positioned as a research acceleration tool — it does not make buy/sell recommendations, but gives individual investors and small fund managers the depth of research previously accessible only to institutional teams with Bloomberg Terminal access and dedicated analyst staff.
Key Features
- Multi-agent 360° stock analysis — Simultaneous AI agent analysis across fundamentals, technicals, sentiment, insider activity, and regulatory filings for any US-listed stock
- Earnings call AI processing — Automatic transcription and analysis of earnings calls; extracts management tone, forward guidance signals, and analyst Q&A themes
- SEC filing analysis — AI processes 10-K, 10-Q, 8-K, and proxy filings to flag material changes in risk factors, accounting adjustments, and strategic language shifts
- Insider trading tracker — Real-time monitoring of Form 4 filings; AI distinguishes between routine compensation transactions and potentially significant directional trades
- News and sentiment intelligence — Continuous news monitoring with AI sentiment scoring; distinguishes between noise and signal in market coverage
- Technical analysis agent — Evaluates price momentum, volume patterns, and key technical levels across multiple timeframes
- Analyst consensus aggregation — Aggregates and synthesises sell-side analyst ratings, price targets, and estimate revisions
- Portfolio monitoring — Track a watchlist of stocks with automated alerts when agent-detected signals cross predefined thresholds
Pricing
Source: sagehood.ai and verified sources, March 2026. Confirm current plans at official site.
- Free trial — Limited stock analysis reports; core agent functionality for evaluation
- Paid plans — from ~$29/month — Full multi-agent analysis; unlimited reports; portfolio monitoring; real-time alerts. Verify current tier structure at official site as pricing has evolved since Product Hunt launch.
- Premium / Pro — Advanced features including deeper SEC filing analysis, extended earnings call history, and priority agent processing
Sagehood vs Bloomberg Terminal vs Perplexity Finance
Sagehood targets a specific gap: individual investors and small fund managers who need institutional-depth research but cannot justify Bloomberg Terminal costs ($24,000+/year per user) or dedicate analyst headcount to compile it manually. Perplexity's finance-focused search provides real-time news and basic financial data with citations, but does not deploy specialised agents across regulatory filings, insider transactions, and earnings call transcripts simultaneously. Sagehood's multi-agent approach produces research with a depth that single-model AI search tools cannot replicate for equity analysis specifically. The limitation is US-market focus — international equities are not currently covered, which restricts the platform's utility for globally diversified portfolios.
Pros & Cons
Pros:
- #13 Product Hunt 2025 — strong community signal in a specialised category with high professional credibility
- Multi-agent architecture produces institutional research depth unavailable from general-purpose AI tools
- SEC filing and insider trading analysis surfaces regulatory signals that most retail investors miss
- Research compilation speed (minutes vs hours) is a genuine edge for time-constrained investors
Cons:
- US equity markets only — no international stock coverage as of March 2026
- Does not provide buy/sell recommendations — output is research input, not actionable signals
- AI analysis of earnings calls and filings can miss nuanced context that experienced human analysts would flag
- Pricing structure not fully transparent on official site — requires evaluation to confirm current tier costs
Who Should Use Sagehood?
Sagehood is the right tool for active individual investors, retail traders, and small RIA or family office teams who research US equities regularly and want to compress multi-hour fundamental research into minutes. It is not a replacement for professional investment advice or institutional-grade data infrastructure, but it closes the research quality gap between individual investors and institutional teams significantly. Users who primarily need real-time price data, options analytics, or international market coverage should evaluate Bloomberg, Koyfin, or Perplexity Finance alongside Sagehood.
Bottom Line
Sagehood is the most capable AI investment research tool for individual US equity investors in 2026 — the multi-agent architecture that simultaneously processes earnings calls, SEC filings, insider trades, and news delivers research depth that no single-model AI tool can match at this price point. The US-only scope is the primary limitation for internationally diversified portfolios. For anyone actively researching US stocks, the research acceleration alone justifies the trial.
